Publications by authors named "Nisha Rizvi"
Article Synopsis
- Lung volume reduction surgery (LVRS) is primarily guided by the National Emphysema Treatment Trial, focusing on patient selection to improve outcomes.* -
- Patients with non-upper lobe emphysema and low exercise capacity are considered poor candidates due to higher mortality and less functional improvement.* -
- For well-selected patients with heterogeneous emphysema, LVRS shows promising long-term survival rates (63% to 78% over 5 years) and may serve as an alternative to lung transplantation.*
Background: Lung volume reduction surgery (LVRS) is the definitive treatment for patients with severe emphysema. There is still a need for long-term data concerning the outcomes of this procedure. This study presents long-term longitudinal data on LVRS including correlation of quality of life (QOL) with pulmonary function testing metrics and includes additional analysis of patients with heterogeneous and homogeneous emphysema.
View Article and Find Full Text PDFBackground And Aim: The importance of glycolysis in cancer cells is well documented. The effects of inhibiting glycolysis using metabolic inhibitors iodoacetate (IAA), an inhibitor of GAPDHase, and 3-bromopyruvate (3BP), an inhibitor of hexokinase-II, on survival and signaling of pancreatic cancer cells (Panc-1) were investigated.
Materials And Methods: Cellular survival was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.